Northwest Biotherapeutics has entered into agreements for large-scale expansion of the manufacturing, storage, handling and distribution of its DCVax-L and DCVax-Direct products, with its long-time contract manufacturer, Cognate Bioservices. The agreement includes development of infrastructure and key systems, and execution of product validation work required for regulatory submissions.   Cognate will provide manufacturing and services for DCVax-L and DCVax-Direct. Additional agreements provide ...